Cook's V-Flex stent begins major European study:
This article was originally published in Clinica
A major European trial is underway in Europe to evaluate the safety and efficacy of Cook's paclitaxel-eluting V-Flex Plus coronary stent in treating patients with in-stent restenosis. Results from the nine-month, multicentre, randomised, controlled In-Stent ELUTES trial, which will enrol 600 patients at 22 sites, will be used to request additional approved indications for the stent, said the Bloomington, Indiana firm.
You may also be interested in...
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.